Pharmaceutical Compliance Congress 2025
Your complete guide to mitigate risk: Stay on the pulse of enforcement trends, supercharge your best practice playbook and expand your network at PCC 2025.
Partner Dominick DiSabatino will be speaking on the panel "Patient Advocacy: New Growing Risk for Compliance?" on April 28 from 5:00-5:45 PM ET.
Panel Discussion Topics:
- How are organizations managing Compliance surrounding patient advocacy and patient education groups?
- Examining differing approaches on transfer of value in meals, speaker honorarium etc
- Internal guidelines and what are they spending on patients, are they allowing alcohol etc?
- How is this spend tracked, and by whom to make sure you don't pay patients "too much"?
- Is there a cap for overall spend per patient/caregiver?
- How is FMV determined?
- What is the role of the Patient Advocate vs Patient or Caregiver?
- How, if at all, does the analysis change post-approval vs. during research?
Partner Scott Liebman will be speaking on the panel "Law Firm Benchmarking Session - Chairs of Life Science Groups in Law Firms" on April 29 from 11:10 AM - 12:10 PM ET.
Panel Discussion Topics:
- What are the next generation of enforcement cases?
- Where are companies focusing? Where are we seeing trends?
- Insiders’ insight: investigations and types of issues companies are struggling with
- Creative strategies being employed to increase market share: key risks and mitigation strategies
- How are you seeing your clients utilizing outside counsel and has the role of outside counsel changed?
Click here to register.